We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$27.8B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+31.84%
1 Year Est. Return
+46.46%
3 Year Est. Return
+129.16%
5 Year Est. Return
+174.16%
10 Year Est. Return
+698%
AUM
$27.8B
AUM Growth
+$4.02B
(+17%)
Cap. Flow
-$324M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
27.66%
Holding
1,111
New
158
Increased
319
Reduced
438
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$325M |
| 2 |
CrowdStrike
CRWD
|
+$225M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$186M |
| 4 |
SNDK
Sandisk
SNDK
|
+$155M |
| 5 |
Sysco
SYY
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$418M |
| 2 |
ServiceNow
NOW
|
+$262M |
| 3 |
Apple
AAPL
|
+$260M |
| 4 |
Masco
MAS
|
+$163M |
| 5 |
Roku
ROKU
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.14% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.2% |
| 5 | Healthcare | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Supernus Pharmaceuticals
SUPN
$2.53B
| $1.93M | 0.01% |
41,593
-1,133
| -3% | -$54.4K |
|
602
Savers
SVV
$1.6B
| $1.93M | 0.01% |
+191,190
| New | +$1.66M |
|
603
Latham Group
SWIM
$835M
| $1.93M | 0.01% |
297,733
-141,396
| -32% | -$794K |
|
604
Owlet
OWLT
$146M
| $1.9M | 0.01% |
330,824
+259,058
| +361% | +$1.37M |
|
605
Donegal Group Class A
DGICA
$722M
| $1.89M | 0.01% |
100,095
-29,132
| -23% | -$506K |
|
606
LXP Industrial Trust
LXP
$3.58B
| $1.87M | 0.01% |
+34,760
| New | +$1.79M |
|
607
National Bank Holdings
NBHC
$1.87B
| $1.87M | 0.01% |
42,063
-5,876
| -12% | -$248K |
|
608
Allegro MicroSystems
ALGM
$6.82B
| $1.87M | 0.01% |
26,833
-281,269
| -91% | -$13.2M |
|
609
Harrow
HROW
$1.44B
| $1.86M | 0.01% |
+43,885
| New | +$1.63M |
|
610
Viridian Therapeutics
VRDN
$2.6B
| $1.86M | 0.01% |
+101,414
| New | +$1.63M |
|
|
BORR
611
Borr Drilling
BORR
$1.4B
| $1.86M | 0.01% |
+449,748
| New | +$2.43M |
|
612
Mistras Group
MG
$609M
| $1.85M | 0.01% |
105,898
-8,579
| -7% | -$153K |
|
613
NOV
NOV
$7.63B
| $1.85M | 0.01% |
+99,536
| New | +$1.98M |
|
614
Highwoods Properties
HIW
$3.44B
| $1.83M | 0.01% |
60,841
+10,547
| +21% | +$273K |
|
615
Sight Sciences
SGHT
$460M
| $1.83M | 0.01% |
338,441
+10,529
| +3% | +$48.5K |
|
616
Titan International
TWI
$538M
| $1.83M | 0.01% |
+237,122
| New | +$1.83M |
|
617
Aveanna Healthcare
AVAH
$2.96B
| $1.82M | 0.01% |
212,197
+925
| +0.4% | +$6.52K |
|
618
Capital City Bank Group
CCBG
$887M
| $1.8M | 0.01% |
36,516
-3,194
| -8% | -$148K |
|
619
G-III Apparel Group
GIII
$1.17B
| $1.79M | 0.01% |
53,031
+29,058
| +121% | +$917K |
|
620
BCB Bancorp
BCBP
$157M
| $1.77M | 0.01% |
164,728
+95,287
| +137% | +$973K |
|
621
Core Scientific
CORZ
$5.75B
| $1.75M | 0.01% |
68,550
-151,118
| -69% | -$3.56M |
|
622
Tompkins Financial
TMP
$1.43B
| $1.75M | 0.01% |
18,530
-4,349
| -19% | -$375K |
|
|
UPB
623
Upstream Bio Inc
UPB
$329M
| $1.75M | 0.01% |
+253,092
| New | +$2.12M |
|
624
BioLife Solutions
BLFS
$1.72B
| $1.75M | 0.01% |
61,852
+50,753
| +457% | +$1.19M |
|
|
NPB
625
Northpointe Bancshares
NPB
$598M
| $1.74M | 0.01% |
90,627
-5,485
| -6% | -$97.9K |
|
Similar funds
UIM
SSA
CAM
CM
Jacobs Levy Equity Management's Q2 2026 Portfolio in Review
As of Q2 2026, Jacobs Levy Equity Management held 1,111 positions worth $27.8B, up 17% from $23.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jacobs Levy Equity Management's Q2 2026 filing shows 158 new, 319 increased, 438 reduced and 177 closed positions. Its largest new stake was Sysco: 1,938,184 shares worth $162M. The largest sale was Qualcomm, an estimated $418M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2026 buy was Sysco: 1,938,184 shares worth $162M.
- Jacobs Levy Equity Management added most to KLA in Q2 2026, an estimated $325M increase.
- Jacobs Levy Equity Management's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $418M.
- Jacobs Levy Equity Management fully exited Roku in Q2 2026, selling an estimated $139M.
- Jacobs Levy Equity Management's ten largest holdings make up 28% of its $27.8B portfolio in Q2 2026.
- Jacobs Levy Equity Management opened 158 new positions and closed 177 in Q2 2026.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $27.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.